Search results for

Search

Please note, search results include issues May/June 2020 and later. Search prior issues

Vol. XXXV No. 1September/October 2022

Prof. Vera Kistiakowsky, 1928-2021

Jonathan A. King, Ruth Perry, Robert P. Redwine
Prof. Vera Kistiakowsky passed away on December 11, 2021 at the age of 93. Dr. Kistiakowsky was the first woman to be appointed a professor of physics at MIT (1972)....

Vol. XXXV No. 1September/October 2022

Lessons on Governance from Yale

Robert Berwick, Nazli Choucri, Jonathan A. King
A recent article in the Chronicle of Higher Education by Len Gutkin, “The Review: The Report Yale Doesn’t Want You to See” (August 22, 2022) is very illuminating about how...

Vol. XXXV No. 1September/October 2022

from the MIT Survey of New Students, 2022 and 2018

Vol. XXXV No. 1September/October 2022

Concern with MIT’s Response to Professor Abbot

Vera Yudovina
To The Faculty Newsletter: As a mother of a 2015 graduate, I fully agree with the opinions of Dr. Geil, and with the open letter. We had sent our son...

Vol. XXXV No. 1September/October 2022

Strengths and Weaknesses of an MIT Education

Daniel Jackson
To The Faculty Newsletter: Thomas Eagar and Alex Slocum nicely outlined some of MIT’s best qualities (“Leadership, Management and Education at MIT, redux“, MIT Faculty Newsletter, May/June 2022). I am...

Vol. XXXIV No. 5May/June 2022

On the Closing of the MIT Pharmacy

Michael J. Cima
To The Faculty Newsletter: I very much agree with this op/ed (“On Closing the MIT Pharmacy“). The closing of the MIT pharmacy was a real shock to me. It comes...

Vol. XXXIV No. 5May/June 2022

Congratulations to our Graduates of the Years of the Pandemic

The Editorial Board of the MIT Faculty Newsletter
MIT’s Faculty honors and takes particular pride in the accomplishments and resilience of the Class of 2022. You have had to navigate and overcome the unprecedented stresses of these recent...

Science is Collaborative and Communication is Key: Lessons from my Postdoc in the King Lab

Kelly Knee King lab postdoc 2007-2011 Director of Translational Medicine, Rare Disease Research Unit, Pfizer Inc. 32 Bartlett Crescent, Brookline MA, 02446 Kelly.Knee@pfizer.com There are a number of things that...

Vol. XXXIV No. 2November/December 2021

Improving MIT’s Written Commitment to Freedom of Expression

Alex Byrne, Bernhardt Trout
There is no single place in MIT’s official documentation where the Institute’s commitment to free expression on campus for all community members is clearly and prominently set out. Policies &...

2022 Reducing the Threat of Nuclear War: Rebuilding a Broader Movement

With Congress appropriating funds for new and upgraded nuclear weapons and delivery systems, the need to counter these misguided policies has become acute. The 2022 Conference will follow the general...
1 2 33 34 35 36 37 38 39 40 41